This company listing is no longer active
Clover Biopharmaceuticals Management
Management Kriterienprüfungen 0/4
Clover Biopharmaceuticals' CEO is Joshua G. Liang, appointed in Dec 2020, has a tenure of 2.75 years. total yearly compensation is CN¥30.29M, comprised of 26.9% salary and 73.1% bonuses, including company stock and options. directly owns 1.48% of the company’s shares, worth HK$18.53M. The average tenure of the management team and the board of directors is 1.7 years and 2 years respectively.
Wichtige Informationen
Joshua G. Liang
Geschäftsführender
CN¥30.3m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 26.9% |
| Amtszeit als Geschäftsführer | 2.8yrs |
| Eigentum des Geschäftsführers | 1.5% |
| Durchschnittliche Amtszeit des Managements | 1.7yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 2yrs |
Jüngste Management Updates
Recent updates
Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -CN¥665m |
| Mar 31 2023 | n/a | n/a | -CN¥2b |
| Dec 31 2022 | CN¥30m | CN¥8m | -CN¥2b |
| Sep 30 2022 | n/a | n/a | -CN¥4b |
| Jun 30 2022 | n/a | n/a | -CN¥6b |
| Mar 31 2022 | n/a | n/a | -CN¥6b |
| Dec 31 2021 | CN¥15m | CN¥8m | -CN¥6b |
| Dec 31 2020 | CN¥4m | CN¥4m | -CN¥913m |
Vergütung im Vergleich zum Markt: Joshua G.'s total compensation ($USD4.14M) is above average for companies of similar size in the Hong Kong market ($USD335.32K).
Entschädigung vs. Einkommen: Joshua G.'s compensation has increased whilst the company is unprofitable.
Geschäftsführer
Joshua G. Liang (30 yo)
2.8yrs
Amtszeit
CN¥30,285,000
Vergütung
Mr. Joshua G. Liang is Executive Director and Chief Executive Officer at Clover Biopharmaceuticals, Ltd. since December 25, 2020. Mr. Liang is primarily responsible for leading the management and operation...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Chief Financial Officer | 1.3yrs | keine Daten | keine Daten | |
| Chief Technology Officer | less than a year | keine Daten | keine Daten | |
| Director of Investor Relations | less than a year | keine Daten | keine Daten | |
| Executive Director of Corporate Communications | less than a year | keine Daten | keine Daten | |
| Chief People Officer | 1.8yrs | keine Daten | keine Daten | |
| Chief Medical Officer of Vaccine | 2.6yrs | keine Daten | keine Daten | |
| Chief Technical Operation Officer | no data | keine Daten | keine Daten | |
| Senior Vice President of Corporate Strategy & Business Development | 1.8yrs | keine Daten | keine Daten | |
| Senior Vice President of Head of Regulatory Affairs | 1.8yrs | keine Daten | keine Daten | |
| President of Global Research & Development | 1.6yrs | keine Daten | keine Daten |
1.7yrs
Durchschnittliche Betriebszugehörigkeit
53yo
Durchschnittliches Alter
Erfahrenes Management: 2197's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Founder | 4.9yrs | CN¥10.45m | 16.19% CN¥ 203.2m | |
| CEO & Executive Director | 2.8yrs | CN¥30.29m | 1.48% CN¥ 18.5m | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k | |
| Non-Executive Director | 1.3yrs | CN¥1.30m | 0.039% CN¥ 484.8k | |
| Non-Executive Director | 2.5yrs | CN¥2.20m | 2.18% CN¥ 27.3m | |
| Non-Executive Director | 1.3yrs | CN¥527.00k | 0.0067% CN¥ 84.6k | |
| Independent Non-Executive Director | 2yrs | CN¥2.32m | 0.011% CN¥ 143.2k | |
| Independent Non-executive Director | 2yrs | CN¥2.29m | 0.011% CN¥ 143.2k | |
| Independent Non-Executive Director | 2yrs | CN¥2.21m | 0.011% CN¥ 143.2k |
2.0yrs
Durchschnittliche Betriebszugehörigkeit
61yo
Durchschnittliches Alter
Erfahrener Vorstand: 2197's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.